News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
630,362 Results
Type
Article (54087)
Company Profile (288)
Press Release (575985)
Multimedia
Podcasts (95)
Webinars (16)
Section
Business (170201)
Career Advice (2454)
Deals (31109)
Drug Delivery (121)
Drug Development (79579)
Employer Resources (153)
FDA (16602)
Job Trends (13465)
News (305220)
Policy (32299)
Tag
Academia (2702)
Academic (1)
Accelerated approval (9)
Adcomms (32)
Allergies (97)
Alliances (44321)
ALS (112)
Alzheimer's disease (1537)
Antibody-drug conjugate (ADC) (171)
Approvals (16550)
Artificial intelligence (318)
Autoimmune disease (34)
Automation (17)
Bankruptcy (328)
Best Places to Work (10544)
BIOSECURE Act (22)
Biosimilars (121)
Biotechnology (193)
Bladder cancer (92)
Brain cancer (37)
Breast cancer (357)
Cancer (2817)
Cardiovascular disease (232)
Career advice (2055)
Career pathing (33)
CAR-T (185)
CDC (37)
Cell therapy (511)
Cervical cancer (24)
Clinical research (65121)
Collaboration (979)
Company closure (3)
Compensation (643)
Complete response letters (30)
COVID-19 (2799)
CRISPR (61)
C-suite (300)
Cystic fibrosis (115)
Data (2812)
Decentralized trials (2)
Denatured (20)
Depression (63)
Diabetes (327)
Diagnostics (6254)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (139)
Drug pricing (144)
Drug shortages (32)
Duchenne muscular dystrophy (124)
Earnings (67093)
Editorial (48)
Employer branding (20)
Employer resources (139)
Events (95928)
Executive appointments (826)
FDA (18167)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (883)
Gene editing (139)
Generative AI (25)
Gene therapy (406)
GLP-1 (878)
Government (4486)
Grass and pollen (6)
Guidances (177)
Healthcare (17214)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (170)
Immuno-oncology (8)
Indications (37)
Infectious disease (2975)
Inflammatory bowel disease (163)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (453)
IPO (15401)
IRA (51)
Job creations (3373)
Job search strategy (1708)
Kidney cancer (14)
Labor market (44)
Layoffs (552)
Leadership (24)
Legal (7389)
Liver cancer (83)
Lung cancer (404)
Lymphoma (195)
Machine learning (9)
Management (52)
Manufacturing (369)
MASH (91)
Medical device (12317)
Medtech (12320)
Mergers & acquisitions (16385)
Metabolic disorders (864)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (135)
Neuropsychiatric disorders (38)
Neuroscience (2241)
NextGen: Class of 2025 (5803)
Non-profit (4457)
Now hiring (28)
Obesity (458)
Opinion (242)
Ovarian cancer (94)
Pain (107)
Pancreatic cancer (111)
Parkinson's disease (191)
Partnered (19)
Patents (293)
Patient recruitment (140)
Peanut (51)
People (50782)
Pharmaceutical (70)
Pharmacy benefit managers (24)
Phase I (19952)
Phase II (28549)
Phase III (21950)
Pipeline (1577)
Policy (221)
Postmarket research (2632)
Preclinical (8441)
Press Release (49)
Prostate cancer (139)
Psychedelics (38)
Radiopharmaceuticals (244)
Rare diseases (494)
Real estate (4914)
Recruiting (61)
Regulatory (22938)
Reports (37)
Research institute (2446)
Resumes & cover letters (408)
Rett syndrome (9)
RNA editing (9)
RSV (53)
Schizophrenia (91)
Series A (159)
Series B (103)
Service/supplier (10)
Sickle cell disease (64)
Special edition (20)
Spinal muscular atrophy (163)
Sponsored (36)
Startups (3306)
State (1)
Stomach cancer (16)
Supply chain (77)
Tariffs (63)
The Weekly (74)
Vaccines (866)
Venture capital (53)
Weight loss (309)
Women's health (39)
Worklife (20)
Date
Today (44)
Last 7 days (484)
Last 30 days (2484)
Last 365 days (31469)
2025 (15569)
2024 (34827)
2023 (39047)
2022 (49933)
2021 (53849)
2020 (51460)
2019 (41907)
2018 (31780)
2017 (31573)
2016 (30472)
2015 (34220)
2014 (27052)
2013 (22277)
2012 (23661)
2011 (23921)
2010 (22154)
Location
Africa (814)
Alabama (56)
Alaska (6)
Arizona (195)
Arkansas (11)
Asia (37532)
Australia (6525)
California (7059)
Canada (2050)
China (644)
Colorado (290)
Connecticut (328)
Delaware (173)
Europe (89064)
Florida (1055)
Georgia (231)
Hawaii (1)
Idaho (55)
Illinois (584)
India (25)
Indiana (321)
Iowa (17)
Japan (209)
Kansas (100)
Kentucky (24)
Louisiana (14)
Maine (66)
Maryland (1009)
Massachusetts (5350)
Michigan (214)
Minnesota (414)
Mississippi (2)
Missouri (82)
Montana (24)
Nebraska (23)
Nevada (71)
New Hampshire (60)
New Jersey (1975)
New Mexico (21)
New York (1991)
North Carolina (1076)
North Dakota (8)
Northern California (3125)
Ohio (207)
Oklahoma (12)
Oregon (34)
Pennsylvania (1496)
Puerto Rico (11)
Rhode Island (28)
South America (1166)
South Carolina (34)
South Dakota (1)
Southern California (2615)
Tennessee (107)
Texas (1028)
United States (26107)
Utah (200)
Virginia (179)
Washington D.C. (73)
Washington State (600)
West Virginia (4)
Wisconsin (70)
630,362 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rune Labs and Parkinson’s Foundation Launch First Clinical Program to Correlate Genetic and Digital Biomarkers for Parkinson’s Disease
May 29, 2025
·
6 min read
Parkinson’s disease
Ventyx’s Parkinson’s Pill Shows ‘Promising’ Results in Mid-Stage Study, Paving Path to Other Neuro Diseases
Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including Alzheimer’s.
June 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
·
5 min read
Press Releases
Casma Therapeutics Nominates CSM-101 as a Development Candidate for the Treatment of Rare and Common Forms of Parkinson’s Disease
June 5, 2025
·
3 min read
Press Releases
ZyVersa Therapeutics Highlights Published Study Reinforcing That Microglia-driven Inflammation Is Pivotal in Development of Parkinson’s and Alzheimer’s Diseases
May 20, 2025
·
6 min read
Press Releases
Capsida Receives FDA IND Clearance for Its IV-Administered Gene Therapy for Parkinson’s Disease Associated With GBA Mutations
June 11, 2025
·
3 min read
Press Releases
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
June 9, 2025
·
3 min read
Press Releases
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
May 13, 2025
·
7 min read
Press Releases
Latus Bio Announces Publication of Breakthrough Research on Novel AAV Capsid Variant for Huntington’s and Parkinson’s Disease Gene Therapy
May 20, 2025
·
3 min read
Press Releases
Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease
May 23, 2025
·
3 min read
1 of 63,037
Next
